Cardano's (CRYPTO: ADA) price has increased 4.25% over the past 24 hours to $0.69, which is in the opposite direction of its trend over the past week, where it has experienced a 11.0% loss, moving from $0.76 to its current price.
The brief revival in U.S. factory activity vanished in March as input prices shot up at the fastest pace since mid-2022, raising red flags about eroding profit margins, cost pass-through risks and strained supply chains as the U.S.
Axsome's Phase 3 trial for solriamfetol in MDD did not meet its primary endpoint, but positive data in severe EDS patients supports plans for a new study in 2025.
Chris Chung, CEO and co-founder of DEX aggregator Titan, has called for the crypto industry to establish ethical norms through social consensus, particularly in response to controversies involving political fundraising via meme coins and token launches.
Roblox is expanding its ad capabilities with Google, enabling brands to buy Rewarded Video ads programmatically. Early tests show over 80% completion rates, with some exceeding 90%.
Gold has started the new quarter hitting fresh record highs, following a massive first quarter during which it rallied 19% and broke lots of milestones, including surpassing the $3000 mark.
Revenue fell 27% year over year to $2.62 million during the quarter, while the company’s net loss narrowed to $3 million or $1.22 per share compared to a loss of $3.16 million or $1.66 per share in the year-ago period.
GlobalFoundries Inc. may merge with United Microelectronics Corp., creating a viable alternative to Taiwan Semiconductor; deal faces Chinese regulatory hurdles.
NISOURCE INC (NYSE:NI) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:NI Could Be on the Verge of a Breakout. Here's What You Need to Know.
BofA flagged that GlobalFoundries’ primary value add compared to its peers is its lack of exposure to China and Taiwan, which "might be negated" by a merger.
Macy's announced a shakeup of its executive leadership team to further advance the company's "Bold New Chapter" strategy designed to return the company to long-term profitable growth.
SenesTech, an under-the-radar biotech company with a focus on solving the global pest population problem through, humane fertility control measures, seems attractively valued.
